Assisted Reproductive Technology Market Size, Revenue Analysis, Industry Report, 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Assisted Reproductive Technology Market Size Analysis

Global Assisted Reproductive Technology Market Introduction
By Procedure
1. Introduction
  1. Procedure By Value
2. In Vitro Fertilization (IVF)
  1. By Value
  2. Fresh Non-Donor
    1. Fresh Non-Donor By Value
  3. Frozen Non-Donor
    1. Frozen Non-Donor By Value
  4. Fresh Donor
    1. Fresh Donor By Value
  5. Frozen Donor
    1. Frozen Donor By Value
3. Artificial Insemination (AI)
  1. By Value
  2. Intravaginal (IVI)
    1. Intravaginal (IVI) By Value
  3. Intrauterine (IUI)
    1. Intrauterine (IUI) By Value
  4. Intracervical (ICI)
    1. Intracervical (ICI) By Value
  5. Intratubal (ITI)
    1. Intratubal (ITI) By Value
By Technology
1. Introduction
  1. Technology By Value
2. Instruments and Equipment
  1. By Value
3. Software and AI Solutions
  1. By Value
4. Accessories and Disposables
  1. By Value
5. Culture Media
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Fertility Clinics and Specialized Facilities
  1. By Value
3. Hospitals and Other Medical Settings
  1. By Value

North America Market Analysis

Introduction
By Procedure
1. Introduction
  1. Procedure By Value
2. In Vitro Fertilization (IVF)
  1. By Value
  2. Fresh Non-Donor
    1. Fresh Non-Donor By Value
  3. Frozen Non-Donor
    1. Frozen Non-Donor By Value
  4. Fresh Donor
    1. Fresh Donor By Value
  5. Frozen Donor
    1. Frozen Donor By Value
3. Artificial Insemination (AI)
  1. By Value
  2. Intravaginal (IVI)
    1. Intravaginal (IVI) By Value
  3. Intrauterine (IUI)
    1. Intrauterine (IUI) By Value
  4. Intracervical (ICI)
    1. Intracervical (ICI) By Value
  5. Intratubal (ITI)
    1. Intratubal (ITI) By Value
By Technology
1. Introduction
  1. Technology By Value
2. Instruments and Equipment
  1. By Value
3. Software and AI Solutions
  1. By Value
4. Accessories and Disposables
  1. By Value
5. Culture Media
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Fertility Clinics and Specialized Facilities
  1. By Value
3. Hospitals and Other Medical Settings
  1. By Value
U.S.
1. By Procedure
  1. Introduction
    1. Procedure By Value
  2. In Vitro Fertilization (IVF)
    1. By Value
    2. Fresh Non-Donor
      1. Fresh Non-Donor By Value
    3. Frozen Non-Donor
      1. Frozen Non-Donor By Value
    4. Fresh Donor
      1. Fresh Donor By Value
    5. Frozen Donor
      1. Frozen Donor By Value
  3. Artificial Insemination (AI)
    1. By Value
    2. Intravaginal (IVI)
      1. Intravaginal (IVI) By Value
    3. Intrauterine (IUI)
      1. Intrauterine (IUI) By Value
    4. Intracervical (ICI)
      1. Intracervical (ICI) By Value
    5. Intratubal (ITI)
      1. Intratubal (ITI) By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Instruments and Equipment
    1. By Value
  3. Software and AI Solutions
    1. By Value
  4. Accessories and Disposables
    1. By Value
  5. Culture Media
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Fertility Clinics and Specialized Facilities
    1. By Value
  3. Hospitals and Other Medical Settings
    1. By Value
Canada

Europe Market Analysis

Introduction
By Procedure
1. Introduction
  1. Procedure By Value
2. In Vitro Fertilization (IVF)
  1. By Value
  2. Fresh Non-Donor
    1. Fresh Non-Donor By Value
  3. Frozen Non-Donor
    1. Frozen Non-Donor By Value
  4. Fresh Donor
    1. Fresh Donor By Value
  5. Frozen Donor
    1. Frozen Donor By Value
3. Artificial Insemination (AI)
  1. By Value
  2. Intravaginal (IVI)
    1. Intravaginal (IVI) By Value
  3. Intrauterine (IUI)
    1. Intrauterine (IUI) By Value
  4. Intracervical (ICI)
    1. Intracervical (ICI) By Value
  5. Intratubal (ITI)
    1. Intratubal (ITI) By Value
By Technology
1. Introduction
  1. Technology By Value
2. Instruments and Equipment
  1. By Value
3. Software and AI Solutions
  1. By Value
4. Accessories and Disposables
  1. By Value
5. Culture Media
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Fertility Clinics and Specialized Facilities
  1. By Value
3. Hospitals and Other Medical Settings
  1. By Value
U.K.
1. By Procedure
  1. Introduction
    1. Procedure By Value
  2. In Vitro Fertilization (IVF)
    1. By Value
    2. Fresh Non-Donor
      1. Fresh Non-Donor By Value
    3. Frozen Non-Donor
      1. Frozen Non-Donor By Value
    4. Fresh Donor
      1. Fresh Donor By Value
    5. Frozen Donor
      1. Frozen Donor By Value
  3. Artificial Insemination (AI)
    1. By Value
    2. Intravaginal (IVI)
      1. Intravaginal (IVI) By Value
    3. Intrauterine (IUI)
      1. Intrauterine (IUI) By Value
    4. Intracervical (ICI)
      1. Intracervical (ICI) By Value
    5. Intratubal (ITI)
      1. Intratubal (ITI) By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Instruments and Equipment
    1. By Value
  3. Software and AI Solutions
    1. By Value
  4. Accessories and Disposables
    1. By Value
  5. Culture Media
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Fertility Clinics and Specialized Facilities
    1. By Value
  3. Hospitals and Other Medical Settings
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Procedure
1. Introduction
  1. Procedure By Value
2. In Vitro Fertilization (IVF)
  1. By Value
  2. Fresh Non-Donor
    1. Fresh Non-Donor By Value
  3. Frozen Non-Donor
    1. Frozen Non-Donor By Value
  4. Fresh Donor
    1. Fresh Donor By Value
  5. Frozen Donor
    1. Frozen Donor By Value
3. Artificial Insemination (AI)
  1. By Value
  2. Intravaginal (IVI)
    1. Intravaginal (IVI) By Value
  3. Intrauterine (IUI)
    1. Intrauterine (IUI) By Value
  4. Intracervical (ICI)
    1. Intracervical (ICI) By Value
  5. Intratubal (ITI)
    1. Intratubal (ITI) By Value
By Technology
1. Introduction
  1. Technology By Value
2. Instruments and Equipment
  1. By Value
3. Software and AI Solutions
  1. By Value
4. Accessories and Disposables
  1. By Value
5. Culture Media
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Fertility Clinics and Specialized Facilities
  1. By Value
3. Hospitals and Other Medical Settings
  1. By Value
China
1. By Procedure
  1. Introduction
    1. Procedure By Value
  2. In Vitro Fertilization (IVF)
    1. By Value
    2. Fresh Non-Donor
      1. Fresh Non-Donor By Value
    3. Frozen Non-Donor
      1. Frozen Non-Donor By Value
    4. Fresh Donor
      1. Fresh Donor By Value
    5. Frozen Donor
      1. Frozen Donor By Value
  3. Artificial Insemination (AI)
    1. By Value
    2. Intravaginal (IVI)
      1. Intravaginal (IVI) By Value
    3. Intrauterine (IUI)
      1. Intrauterine (IUI) By Value
    4. Intracervical (ICI)
      1. Intracervical (ICI) By Value
    5. Intratubal (ITI)
      1. Intratubal (ITI) By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Instruments and Equipment
    1. By Value
  3. Software and AI Solutions
    1. By Value
  4. Accessories and Disposables
    1. By Value
  5. Culture Media
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Fertility Clinics and Specialized Facilities
    1. By Value
  3. Hospitals and Other Medical Settings
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Procedure
1. Introduction
  1. Procedure By Value
2. In Vitro Fertilization (IVF)
  1. By Value
  2. Fresh Non-Donor
    1. Fresh Non-Donor By Value
  3. Frozen Non-Donor
    1. Frozen Non-Donor By Value
  4. Fresh Donor
    1. Fresh Donor By Value
  5. Frozen Donor
    1. Frozen Donor By Value
3. Artificial Insemination (AI)
  1. By Value
  2. Intravaginal (IVI)
    1. Intravaginal (IVI) By Value
  3. Intrauterine (IUI)
    1. Intrauterine (IUI) By Value
  4. Intracervical (ICI)
    1. Intracervical (ICI) By Value
  5. Intratubal (ITI)
    1. Intratubal (ITI) By Value
By Technology
1. Introduction
  1. Technology By Value
2. Instruments and Equipment
  1. By Value
3. Software and AI Solutions
  1. By Value
4. Accessories and Disposables
  1. By Value
5. Culture Media
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Fertility Clinics and Specialized Facilities
  1. By Value
3. Hospitals and Other Medical Settings
  1. By Value
UAE
1. By Procedure
  1. Introduction
    1. Procedure By Value
  2. In Vitro Fertilization (IVF)
    1. By Value
    2. Fresh Non-Donor
      1. Fresh Non-Donor By Value
    3. Frozen Non-Donor
      1. Frozen Non-Donor By Value
    4. Fresh Donor
      1. Fresh Donor By Value
    5. Frozen Donor
      1. Frozen Donor By Value
  3. Artificial Insemination (AI)
    1. By Value
    2. Intravaginal (IVI)
      1. Intravaginal (IVI) By Value
    3. Intrauterine (IUI)
      1. Intrauterine (IUI) By Value
    4. Intracervical (ICI)
      1. Intracervical (ICI) By Value
    5. Intratubal (ITI)
      1. Intratubal (ITI) By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Instruments and Equipment
    1. By Value
  3. Software and AI Solutions
    1. By Value
  4. Accessories and Disposables
    1. By Value
  5. Culture Media
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Fertility Clinics and Specialized Facilities
    1. By Value
  3. Hospitals and Other Medical Settings
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Procedure
1. Introduction
  1. Procedure By Value
2. In Vitro Fertilization (IVF)
  1. By Value
  2. Fresh Non-Donor
    1. Fresh Non-Donor By Value
  3. Frozen Non-Donor
    1. Frozen Non-Donor By Value
  4. Fresh Donor
    1. Fresh Donor By Value
  5. Frozen Donor
    1. Frozen Donor By Value
3. Artificial Insemination (AI)
  1. By Value
  2. Intravaginal (IVI)
    1. Intravaginal (IVI) By Value
  3. Intrauterine (IUI)
    1. Intrauterine (IUI) By Value
  4. Intracervical (ICI)
    1. Intracervical (ICI) By Value
  5. Intratubal (ITI)
    1. Intratubal (ITI) By Value
By Technology
1. Introduction
  1. Technology By Value
2. Instruments and Equipment
  1. By Value
3. Software and AI Solutions
  1. By Value
4. Accessories and Disposables
  1. By Value
5. Culture Media
  1. By Value
By End User
1. Introduction
  1. End User By Value
2. Fertility Clinics and Specialized Facilities
  1. By Value
3. Hospitals and Other Medical Settings
  1. By Value
Brazil
1. By Procedure
  1. Introduction
    1. Procedure By Value
  2. In Vitro Fertilization (IVF)
    1. By Value
    2. Fresh Non-Donor
      1. Fresh Non-Donor By Value
    3. Frozen Non-Donor
      1. Frozen Non-Donor By Value
    4. Fresh Donor
      1. Fresh Donor By Value
    5. Frozen Donor
      1. Frozen Donor By Value
  3. Artificial Insemination (AI)
    1. By Value
    2. Intravaginal (IVI)
      1. Intravaginal (IVI) By Value
    3. Intrauterine (IUI)
      1. Intrauterine (IUI) By Value
    4. Intracervical (ICI)
      1. Intracervical (ICI) By Value
    5. Intratubal (ITI)
      1. Intratubal (ITI) By Value
2. By Technology
  1. Introduction
    1. Technology By Value
  2. Instruments and Equipment
    1. By Value
  3. Software and AI Solutions
    1. By Value
  4. Accessories and Disposables
    1. By Value
  5. Culture Media
    1. By Value
3. By End User
  1. Introduction
    1. End User By Value
  2. Fertility Clinics and Specialized Facilities
    1. By Value
  3. Hospitals and Other Medical Settings
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Assisted Reproductive Technology Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

CooperSurgical
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Ferring Pharmaceuticals
Hamilton Thorne
Vitrolife
Genea
California Cryobank
European Sperm Bank
INVO Bioscience
Monash IVF Group
Progyny
Microm
OvaScience
Bloom IVF Centre
Virtus Health
IVI RMA Global
New Hope Fertility Center
CCRM Fertility
Sher Fertility Institute

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment